HCID 66711468, 화합물 → HCID 66710960, 화합물

HRID 1262051노트

반응식

HRID 1262051 반응식
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH2:13][CH2:12][CH2:11][C@H:10]([C:14]([N:16]3[CH2:21][CH2:20][N:19]([CH3:22])[CH2:18][CH2:17]3)=O)[CH2:9]2)=[CH:4][C:3]=1[O:23][CH3:24].COC1C=C(N2CCC[C@@H](CN3CCN(C)CC3)C2)C=CC=1[N+]([O-])=O>>[CH3:24][O:23][C:3]1[CH:4]=[C:5]([N:8]2[CH2:13][CH2:12][CH2:11][C@@H:10]([CH2:14][N:16]3[CH2:17][CH2:18][N:19]([CH3:22])[CH2:20][CH2:21]3)[CH2:9]2)[CH:6]=[CH:7][C:2]=1[NH2:1]

참가 물질

3

반응물 2

HCID 66711468HCID 66711468, 화합물HCID 66711617HCID 66711617, 화합물

생성물 1

HCID 66710960HCID 66710960, 화합물

실험 절차

2-Methoxy-4-[(S)-3-(4-methyl-piperazin-1-ylmethyl)-piperidin-1-yl]-phenylamine was prepared in an analogous fashion to [(S)-1-(4-Amino-3-methoxy-phenyl)-piperidin-3-yl]-(4-methyl-piperazin-1-yl)-methanone of Example 460c replacing [(S)-1-(3-Methoxy-4-nitro-phenyl)-piperidin-3-yl]-(4-methyl-piperazin-1-yl)-methanone with 1-[(S)-1-(3-Methoxy-4-nitro-phenyl)-piperidin-3-ylmethyl]-4-methyl-piperazine. (160 mg, 97%). LC/MS (E/I+) 319.21 (M+H).

출처 및 근거

ORD 기록
ord-67d2323a896440e7908540725356b803
출처 데이터셋
uspto-grants-2013_06
특허 번호
US08471005B2

반응 노트

불러오는 중…